gabexate has been researched along with Struma Ovarii in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Struma Ovarii: A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. (Dorland, 27th ed; Segen, Dictionary of Modern Medicine, 1992)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakura, H | 1 |
| Fujii, T | 1 |
| Okamoto, K | 1 |
1 other study available for gabexate and Struma Ovarii
| Article | Year |
|---|---|
A study of human calcitonin in an ovarian carcinoid and ovarian cancers.
Topics: Aprotinin; Benzamidines; Biomarkers, Tumor; Calcitonin; Carcinoid Tumor; Chromatography, Gel; Edetic | 1991 |